Core Market Insights - The Global Diagnostic Labs Market is projected to grow at a CAGR of approximately 6.66%, reaching USD 223 billion by 2032, driven by increasing demand for early and accurate disease diagnosis, rising burden of chronic and infectious diseases, and advancements in diagnostic technologies [1][4] - North America dominated the market in 2025, accounting for nearly 40% of total revenue, supported by advanced healthcare infrastructure and high diagnostic testing volumes [2][9] Market Forces Driving Growth - The rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer is significantly increasing the demand for diagnostic testing services [3] - There is a shift towards preventive healthcare, leading to increased routine diagnostic testing and health screening programs, driven by public awareness and government initiatives [3] - Continuous advancements in diagnostic technologies, including molecular diagnostics and AI-driven solutions, are enhancing testing accuracy and efficiency [3][5] Competitive Landscape - Leading companies in the global market include SYNLAB International GmbH, Cerba Healthcare, Unilabs, Quest Diagnostics Incorporated, and Laboratory Corporation of America Holdings (Labcorp), with the top five players accounting for around 50% of the market share [4][12] - Hospital-based laboratories accounted for nearly 50% of the market share in 2025, reflecting their central role in integrated healthcare delivery systems [4][7] Market Segmentation - General and clinical testing captured approximately 45% of the market share in 2025, driven by high volumes of routine diagnostic procedures [4][8] - By lab type, hospital-based laboratories are the dominant segment, benefiting from integration within hospital ecosystems and direct access to patient data [7] Regional Insights - North America is expected to maintain its leadership in the diagnostic labs market, supported by innovative diagnostic technologies and a strong presence of major market players [9][10] - The diagnostic labs market in the US was estimated at USD 34.24 billion in 2025 and is projected to grow to USD 56.88 billion by 2032, with a CAGR of around 7.52% [15]

Core Viewpoint - Nanox Imaging Ltd. has signed a distribution agreement with Imperial Imaging Technology to enhance the commercial rollout of its Nanox.ARC system in six southeastern U.S. states, focusing on orthopedic practices and improving access to advanced imaging technology [1][3][4]. Group 1: Distribution Agreement Details - The agreement designates Imperial Imaging as the distributor for the Nanox.ARC system in Georgia, Alabama, Tennessee, North Carolina, South Carolina, and Northern Florida [3]. - Imperial Imaging will handle marketing, sales, customer support, product demonstrations, and clinical evaluations for orthopedic practices [3][4]. Group 2: Market Expansion Strategy - This partnership aligns with Nanox's strategy to build a diverse network of regional distributors with expertise in orthopedic and musculoskeletal practices [4]. - The collaboration aims to expand access to advanced musculoskeletal imaging directly within orthopedic practices, improving patient care and clinical workflows [5][7]. Group 3: Technology and Benefits - The Nanox.ARC system offers 3D imaging capabilities at a lower cost and reduced radiation dose compared to traditional CT scans [2]. - The system is reimbursable under an existing CPT code, eliminating the need for pre-authorization, which can reduce administrative burdens and expedite patient treatment [5][7]. Group 4: Company Background - Imperial Imaging, founded in 2019, has quickly established itself as a leading distributor in the orthopedic community, known for its service and installation expertise [6]. - Nanox aims to drive the transition to preventive healthcare through an integrated medical imaging and healthcare services platform, combining affordable imaging hardware, AI solutions, and cloud-based software [8][9].

Market Overview - The Personalized Nutrition Market was valued at USD 15.80 billion in 2025 and is projected to reach USD 60.92 billion by 2035, growing at a CAGR of 15.04% from 2026 to 2035 [1][7]. Market Drivers - Rising awareness of preventive healthcare, increasing lifestyle-related chronic diseases, and growing demand for customized wellness solutions are key factors driving the market [2]. - Consumers are increasingly seeking individualized diet plans, DNA-based programs, nutrigenomics testing, and AI-powered supplement recommendations [2]. Regional Insights - The United States is the market leader, with an estimated worth of USD 5.85 billion in 2025 and a projected CAGR of 15.11%, reaching USD 22.27 billion by 2035 [4]. - North America held over 38.64% of the market share in 2025, attributed to high consumer literacy around preventive health and the advantages of DNA-based dietary programs [15]. - Asia Pacific is the fastest-growing segment with a CAGR of 17.43%, driven by increasing awareness of precision dietary solutions and government health initiatives [14]. Market Segmentation - By Product: Dietary supplements & nutraceuticals accounted for approximately 42.36% of revenue in 2025, while the digitized DNA segment is expected to grow at nearly 17.82% CAGR [9]. - By End-User: The direct-to-consumer segment held about 53.28% of the market share and is projected to grow at a CAGR of around 15.63% [10]. - By Measurement Method: Active measurement dominated with a 61.47% share in 2025, driven by real-time monitoring capabilities [11]. - By Form: Capsules held a leading share of 34.19% in 2025, while the powder segment is projected to grow at the highest CAGR of 16.54% [12]. - By Application: Standard supplements accounted for 48.73% of the market, with the disease-based segment expected to expand at a CAGR of 16.91% [13]. Major Players - Key players in the market include Nestlé S.A., Amway Corporation, Herbalife Nutrition Ltd., and Abbott Laboratories [16][20]. - Recent developments include Nestlé's expansion of its personalized nutrition portfolio with AI-powered tools and Amway's launch of a DNA-linked supplement platform [20].

Collaboration with Intec SRL drives commercial expansion of 3D medical imaging across a high-growth private healthcare market PETACH TIKVA, Israel, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (“Nanox”, Nasdaq: NNOX), a leader in innovative medical imaging technology, today announced a distribution agreement with Intec SRL, an Argentina-based medical device distributor with more than 35 years of experience delivering advanced imaging technologies to healthcare providers nationwide. The Nanox.ARC is ...

Core Viewpoint - The FDA has granted 510(k) clearance for TAP2D, a new cloud-enabled image enhancement capability for Nanox's digital tomosynthesis systems, marking a significant step in the company's regulatory strategy to establish its systems as primary diagnostic solutions [1][4]. Group 1: Product Development and Features - The TAP2D capability provides radiologists with an additional 2D view generated from digital tomosynthesis scans, enhancing evaluation while maintaining workflow efficiency [2]. - Nanox.ARC and Nanox.ARC X systems utilize advanced 3D imaging technology, offering enhanced diagnostic capabilities at a lower cost and radiation dose compared to traditional systems [3]. - Software upgrades and new capabilities like TAP2D can be added remotely to the Nanox.ARC systems following regulatory clearances [3]. Group 2: Company Vision and Strategy - The company aims to remove the adjunctive use of its systems in the U.S., allowing Nanox.ARC to function as a standalone primary imaging solution, similar to its status in Europe under CE Mark certification [4]. - Nanox is focused on delivering innovations that improve patient care and expand access to high-quality imaging globally [4]. - The company's vision includes expanding medical imaging access beyond traditional hospital settings by providing a seamless solution from scan to interpretation [6]. Group 3: Ecosystem and Services - The Nanox ecosystem includes various components such as Nanox.ARC, Nanox.AI for AI-driven analytics, Nanox.CLOUD for data management, and Nanox Health IT for healthcare IT solutions [7]. - By integrating imaging technology, AI, cloud infrastructure, and clinical expertise, Nanox seeks to lower barriers to adoption and advance preventive care worldwide [8].

Core Insights - Nanox's AI solutions, HealthOST and HealthVCF, have been recommended for use in UK NHS hospitals for three years as part of an evaluation of AI in bone disease detection [1][2][3] - The National Institute for Health and Care Excellence (NICE) has included these solutions in an Early Value Assessment to gather evidence on their effectiveness in detecting vertebral fragility fractures [2][3] - The AI technologies aim to enhance the detection of vertebral fragility fractures through opportunistic detection in X-ray images and CT scans [3] Company Overview - Nanox.AI is a subsidiary of Nanox focused on deep-learning medical imaging analytics, targeting chronic and acute diseases [6] - The company aims to drive the transition to preventive healthcare by providing affordable medical imaging technologies [7] - Nanox's ecosystem includes various components such as Nanox.ARC, Nanox.AI, Nanox.CLOUD, and Nanox.MARKETPLACE, all designed to improve early detection and treatment [8] Product Details - HealthOST and HealthVCF utilize existing CT scans to support early detection of bone diseases without additional imaging or radiation exposure [4] - These solutions are integrated with existing PACS workflows, allowing real-time identification of clinically significant findings [5] - The tools are expected to improve patient outcomes by enabling timely preventive interventions for conditions like osteoporosis [5]

Industry Overview - Health and fitness companies are experiencing consistent demand due to increasing global awareness of health issues and the significance of physical fitness, driven by rising lifestyle-related diseases and a focus on preventive healthcare [1][10] - The industry's growth is supported by diverse revenue streams, including subscriptions, product sales, and services, making it appealing to long-term investors [2] Company Highlights Doximity Inc. (DOCS) - Doximity is a cloud-based digital platform for medical professionals in the U.S., covering over 80% of U.S. doctors and 60% of advanced practitioners, with a 95% subscription-based revenue model [7] - The company is expanding in a total addressable market of $18.55 billion and has integrated generative AI, enhancing product stickiness and physician utility [8] - Doximity's AI tools have seen a 5x usage growth year-over-year, supporting physicians in managing clinical documentation [9] - Expected revenue and earnings growth rates are 11.2% and 7%, respectively, for the current year [11] Planet Fitness Inc. (PLNT) - Planet Fitness is a leading franchisor and operator of fitness centers in the U.S., benefiting from higher royalties, new club openings, and member acquisitions [12] - The company ended Q2 with approximately 20.8 million members and over 2,762 clubs, achieving an 8.2% year-over-year increase in same-club sales [13] - Expected revenue and earnings growth rates are 10.2% and 13.1%, respectively, for the current year [14] United Natural Foods Inc. (UNFI) - United Natural Foods has shown strong growth supported by wholesale momentum and demand for natural and organic products, with strategic initiatives driving efficiency and cost savings [15][16] - The company has an expected revenue growth rate of 2.5% and earnings growth rate of over 100% for the current year [17] Peloton Interactive Inc. (PTON) - Peloton is evolving from a connected fitness brand to a broader wellness platform, leveraging commercial partnerships to drive growth [18] - The company has seen momentum in its Peloton for Business segment, with partnerships enhancing brand visibility [19] - Expected revenue and earnings growth rates are -1.1% and over 100%, respectively, for the current year [21] Performance Food Group Co. (PFGC) - Performance Food Group markets and distributes a wide range of food products, serving various sectors including restaurants and healthcare facilities [23][24] - The company has an expected revenue growth rate of 6.4% and earnings growth rate of 11.2% for the current year [25]

Core Insights - EUDA Health Holdings Limited is expanding into the Indian market through a partnership with SafeRock India, aiming to leverage the growing wellness and preventive healthcare industry in India [1][3]. Market Opportunity and Growth Potential - India is becoming a significant player in the global wellness and preventive healthcare sector, driven by a growing middle class, urbanization, and a focus on long-term health [2]. - Consumers are increasingly seeking healthier lifestyles and science-based solutions that align with modern living [2]. Partnering for Rapid Strategic Market Entry - The partnership with SafeRock India allows CK Health Plus to enter one of the largest and fastest-growing wellness markets, with plans to expand into major cities like Mumbai, Bangalore, and Karnataka [3]. Building a Sustainable Wellness Ecosystem - The collaboration combines CK Health Plus' Bioenergy Capsule Therapies and EUDA Helixé supplements with SafeRock India's operational presence, aiming to create a sustainable wellness ecosystem [4]. Executive Commentary - The CEO of CK Health Plus emphasized that the partnership with SafeRock India is crucial for delivering scientifically-backed wellness solutions across India, aligning with the company's mission to enhance preventive healthcare accessibility [5]. About EUDA Health Holdings Limited - EUDA Health Holdings Limited focuses on non-invasive healthcare in Asia, particularly in Singapore, Malaysia, and China, targeting the growing longevity sector and addressing the healthcare needs of over 1.8 billion people in the region [6].

Healthcare Challenges in Pakistan - Pakistan's healthcare system lacks proper facilities, requiring imports even for basic equipment [2] - Patients face fragmented care with disconnected doctors, pharmacies, and labs, lacking digital records [3] - The healthcare system is described as dangerous, with chronic diseases potentially pushing middle-class families into poverty [4] - Poverty can be a more immediate threat to life than disease [6] Mary Pharmacy's Vision and Approach - The company aims to simplify healthcare in Pakistan by reimagining the role of a pharmacy [7] - It started as a store offering medicines via walk-in, call, or app orders [8] - Counseling is a cornerstone of the service delivery model [8] - The company has expanded beyond medicines through a partner network, offering health camps focused on preventive healthcare and disease management [9] - Digital prescription records are maintained from inception [10] - The company has grown into a healthcare hub with a network of 26 pharmacies across the city, serving approximately 250万 patients [11]

Core Insights - Health and fitness companies are experiencing consistent demand driven by global awareness of health issues and the importance of physical fitness, supported by rising lifestyle-related diseases and preventive healthcare emphasis [3] - The growth of the health and fitness sector is bolstered by diverse revenue streams, including subscriptions, product sales, and services, making it attractive for long-term investors [4] Company Summaries NIKE Inc. (NKE) - NIKE is benefiting from the execution of its "Win Now" strategy and recovery in wholesale orders, which may lead to revenue acceleration in fiscal 2026 [8] - The "Win Now" strategy aims to restore brand momentum and includes five key actions: culture, product, marketing, marketplace, and ground game [10] - NIKE's expected revenue and earnings growth rates are -1.3% and -21.8%, respectively, for the current year, with a 1.2% improvement in the Zacks Consensus Estimate for current-year earnings over the past 60 days [11] Sprouts Farmers Market Inc. (SFM) - Sprouts Farmers is focused on product innovation, e-commerce, and expanding private label offerings, which strengthens its position in the natural and organic grocery space [12] - Investments in supply chain modernization and self-distribution are expected to enhance freshness and operational efficiency, while new store formats broaden geographic reach [13] - SFM's expected revenue and earnings growth rates are 15.7% and 40.8%, respectively, for the current year, with a 0.8% improvement in the Zacks Consensus Estimate for current-year earnings over the past 30 days [14] Peloton Interactive Inc. (PTON) - Peloton offers fitness products accessible through various devices, providing a comprehensive slate of fitness offerings [15] - Peloton's expected revenue and earnings growth rates are -1.8% and more than 100%, respectively, for the current year, with the Zacks Consensus Estimate for current-year earnings improving by more than 100% over the last 60 days [16]